Publicaciones en las que colabora con Javier Arbizu Lostao (22)

2020

  1. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 8, pp. 1885-1912

  2. Proven validity and management impact of amyloid imaging in Alzheimer’s disease—repetita juvant

    European Journal of Nuclear Medicine and Molecular Imaging

2014

  1. In vivo monitoring of staphylococcus aureus biofilm infections and antimicrobial therapy by [18F] Fluoro-Deoxyglucose-MicroPET in a Mouse Model

    Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 11, pp. 6660-6667

  2. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway

    Neurobiology of Disease, Vol. 62, pp. 250-259

  3. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization

    Medical Physics, Vol. 41, Núm. 9

2013

  1. Aportación del tiempo de vuelo y de la modelización de la respuesta a una fuente puntual a las características de funcionamiento del tomógrafo PET/TAC Biograph mCT

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 32, Núm. 1, pp. 13-21

  2. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 9, pp. 1394-1405

2012

  1. Decreased carbon-11-flumazenil binding in early Alzheimer's disease

    Brain, Vol. 135, Núm. 9, pp. 2817-2825

  2. Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: Patterns of integration in therapy planning

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Núm. 5, pp. 771-781

  3. Tomografía por emisión de positrones en tumores del sistema nervioso central

    Medicina nuclear en la práctica clínica (Aula Médica Ediciones), pp. 769-778

2011

  1. Dual time point 18F-FDOPA PET as a tool for characterizing brain tumors

    Revista Espanola de Medicina Nuclear, Vol. 30, Núm. 2, pp. 88-93

  2. PET de doble fase con 18F-FDOPA como instrumento para la caracterización de tumores cerebrales

    Revista española de medicina nuclear, Vol. 30, Núm. 2, pp. 88-93

  3. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation

    Journal of Nuclear Medicine, Vol. 52, Núm. 6, pp. 865-872

2010

  1. Evaluation of spatial resolution of a PET scanner through the simulation and experimental measurement of the recovery coefficient

    Computers in Biology and Medicine, Vol. 40, Núm. 1, pp. 75-80

  2. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study

    Neurobiology of Disease, Vol. 38, Núm. 3, pp. 456-463

2009

  1. New MRI, 18F-DOPA and 11C-(+)-α-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: Advantages to improve PET quantification

    NeuroImage, Vol. 47, Núm. 2, pp. 533-539

2008

  1. Síntesis rápida y simplificada de 11C-(+)-α- dihidrotetrabenazina para su utilización como radioligando PET de los transportadores vesiculares de monoaminas

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 1, pp. 13-21

  2. Utilización de la11C-(+)-α-dihidrotetrabenazina para la evaluación de la inervación dopaminérgica en modelos animales de la enfermedad de Parkinson

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 2, pp. 103-111

2006

  1. Simple automated system for simultaneous production of 11C-labeled tracers by solid supported methylation

    Applied Radiation and Isotopes, Vol. 64, Núm. 7, pp. 808-811

2002

  1. Functional neuroanatomy of sustained attention in schizophrenia: Contribution of parietal cortices

    Human Brain Mapping, Vol. 17, Núm. 2, pp. 116-130